Greg Mattingly, MD, Associate Clinical Professor, Washington University, St. Louis, Missouri, discusses needs that remain unmet in the treatment of depression.
COPD affects more than 16 million Americans. During his session at the American Lung Association’s LUNGFORCE Expo, Andrew Berman, MD, discussed pharmacologic and nonpharmacologic therapy options for...
He talks about how and why metabolic pathways are targeted when treating nonalcoholic fatty liver disease. He recently spoke about this topic at the 21st Annual Harvard Nutrition and Obesity Symposium on...
Phil Lempert discusses the results of a recent report by the Food Industry Association and Saint Joseph’s University on ways in which food retailers can attract younger employees.
